Doseology Sciences (MOOD) Stock Price & Analysis

6 Followers

MOOD Stock Chart & Stats

CA$0.11CA$0.01(10.00%)

At close: Nov 10 4:00 PM EST

Day’s Range: CAD 0.11 - CAD 0.11
52-Week Range: CAD 0.08 - CAD 1.00
Previous Close: CAD 0.10
Volume: N/A
Average Volume (3M): 3,477
Market Cap: CAD 881.28K
Enterprise Value: CAD 6.33M
Total Cash (Recent Filing): CAD 1.43M
Total Debt (Recent Filing): CAD 0
Price to Earnings (P/E): ―
Beta: -3.31
Next Earnings: Nov 26, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

A near-zero debt position and equity cushion materially reduce leverage risk and give the company more financing flexibility over the medium term. This durable strength lowers default risk and supports strategic options (M&A, licensing, or capital raises) while losses persist.

Positive Gross Profit

Sustained positive gross profit indicates product-level economics and some pricing or cost advantage at the revenue unit level. If operating cost discipline continues, positive gross margins provide a credible path to operating leverage and eventual profitability over several quarters.

Improved Cash Burn

Material improvement in cash burn shows management has tightened spending and improved cash stewardship. That extends runway versus prior years, reducing immediate dilution risk and giving time to execute strategic priorities or secure financing under better terms.

Bears Say

Persistent Operating Losses

Large ongoing operating deficits relative to revenue show the business has not scaled to cover fixed costs. Persistent losses will continue to erode equity, limit reinvestment capacity, and force reliance on external capital unless meaningful margin improvements are achieved.

Negative Operating Cash Flow

Repeated negative operating and free cash flow, including roughly -$342K in 2025, means core operations do not self-fund. For a small company this necessitates further capital raises, increases dilution risk, and creates execution uncertainty over the next several quarters.

Small, Volatile Revenue

Very small and erratic revenue undermines scale economies and makes forecasting and investment planning difficult. A ~27% decline in 2025 signals demand or commercial execution issues that structurally constrain margin expansion and sustainable growth without strategic change.

Doseology Sciences News

Doseology MCTO Revoked as Company Adopts Semi-Annual Reporting

Doseology Sciences ( ($TSE:MOOD) ) has issued an update. Doseology Sciences develops pouch-based oral stimulant and cognitive-support products for consumers seeking discreet, smokeless and vapor-free alternatives to traditional delivery formats.

1w agoVU70 MOOD

Doseology Director Resigns as Company Pursues Growth in Oral Stimulant Pouch Market

Doseology Sciences ( ($TSE:MOOD) ) has issued an update. Doseology Sciences Inc. announced that director Larry Latowsky has resigned from the company’s board, effective immediately. The change comes as Doseology

4w agoVU70 MOOD

Doseology revamps leadership and settles consultant debt with share issuance

Doseology Sciences ( ($TSE:MOOD) ) has shared an announcement. Doseology Sciences Inc. has overhauled its leadership team, appointing operations and supply chain specialist Kareem Baalbaki as interim CEO, interim CFO

1M agoVU70 MOOD

Doseology Settles Consultant Debt in Shares as Director Resigns

An announcement from Doseology Sciences ( ($TSE:MOOD) ) is now available. Doseology Sciences Inc., a specialist in pouch-based oral stimulant and cognitive support products, is positioning itself in a fast-growing

1M agoVU70 MOOD

Doseology launches $2 million private placement to fund oral stimulant pouch rollout

Doseology Sciences ( ($TSE:MOOD) ) has issued an announcement. Doseology Sciences Inc. has arranged a non-brokered private placement of up to 3,225,806 units at $0.62 per unit to raise as

7M agoVU70 MOOD

Doseology Uplists to OTCQB to Advance Growth in Oral Stimulant Pouch Market

An announcement from Doseology Sciences ( ($TSE:MOOD) ) is now available. Doseology Sciences Inc. has uplisted its common shares to the OTCQB Venture Market in the United States under the

8M agoVU70 MOOD

Doseology debuts nicotine-free energy pouches in U.S. direct-to-consumer pilot

Doseology Sciences ( ($TSE:MOOD) ) has shared an announcement. Doseology Sciences has launched its Feed That Brain Energy Pouches in the U.S. through its first direct-to-consumer pilot, offering nicotine-free, caffeine-based

8M agoVU70 MOOD

Doseology Taps Veteran Pharmacy Executive Larry Latowsky as Executive Chairman to Steer Commercial Expansion

Doseology Sciences ( ($TSE:MOOD) ) just unveiled an update. Doseology Sciences has appointed veteran retail and healthcare executive Larry Latowsky as a director and Executive Chairman of its board, signaling

8M agoVU70 MOOD

Doseology Launches Pilot for Caffeine Energy Pouches Under Feed That Brain Brand

Doseology Sciences ( ($TSE:MOOD) ) just unveiled an update. Doseology Sciences has begun a pilot production run of non-nicotine, caffeine-based energy pouches under its Feed That Brain brand, positioning the

9M agoVU70 MOOD

Doseology Boosts Transparency With New Annual Information Form Filing

Doseology Sciences ( ($TSE:MOOD) ) has issued an update. Doseology Sciences Inc. has filed its Annual Information Form for the fiscal year ended June 30, 2025 on SEDAR+, consolidating its

10M agoVU70 MOOD

MOOD FAQ

What was Doseology Sciences’s price range in the past 12 months?

Doseology Sciences lowest stock price was C$0.08 and its highest was C$1.00 in the past 12 months.

What is Doseology Sciences’s market cap?

Doseology Sciences’s market cap is C$881.28K.

When is Doseology Sciences’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Doseology Sciences’s earnings last quarter?

Doseology Sciences released its earnings results on Jun 01, 2026. The company reported -C$0.034 earnings per share for the quarter.

Is Doseology Sciences overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Doseology Sciences pay dividends?

Doseology Sciences does not currently pay dividends.

What is Doseology Sciences’s EPS estimate?

Doseology Sciences’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Doseology Sciences have?

Doseology Sciences has 8,011,621 shares outstanding.

What happened to Doseology Sciences’s price movement after its last earnings report?

Doseology Sciences reported an EPS of -C$0.034 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Doseology Sciences?

Currently, no hedge funds are holding shares in TSE:MOOD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description